Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.
about
Homeostatic disinhibition in the aging brain and Alzheimer's diseaseαν and β1 Integrins mediate Aβ-induced neurotoxicity in hippocampal neurons via the FAK signaling pathway.RAGE regulation and signaling in inflammation and beyond.Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study.
P2860
Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid-modifying therapies fo ...... progress and its implications.
@en
Amyloid-modifying therapies fo ...... progress and its implications.
@nl
type
label
Amyloid-modifying therapies fo ...... progress and its implications.
@en
Amyloid-modifying therapies fo ...... progress and its implications.
@nl
prefLabel
Amyloid-modifying therapies fo ...... progress and its implications.
@en
Amyloid-modifying therapies fo ...... progress and its implications.
@nl
P2860
P1433
P1476
Amyloid-modifying therapies fo ...... progress and its implications.
@en
P2093
Meaghan C Creed
Norton W Milgram
P2860
P304
P356
10.1007/S11357-010-9142-Z
P577
2010-04-20T00:00:00Z